Skip to content

Home

info@nutrigenomicsinstitute.com (+34) 91 9619057
My Account
Linkedin page opens in new windowFacebook page opens in new windowInstagram page opens in new window

Instituto Nutrigenomica

Nutrigenomics Institute
Nutrigenomics and Nutrigenetics Online Courses
Nutrigenomics Institute
  • About Us
  • Our Courses
    • ONLINE COURSE ON NUTRIGENOMICS FOR PROFESSIONALS OF NUTRITION
    • ONLINE COURSE ON NUTRIGENOMICS FOR HEALTH AND SPORTS
    • ONLINE ADVANCED COURSE ON NUTRIGENETICS AND NUTRIGENOMICS FOR PROFESSIONALS OF NUTRITION
  • Teachers
    • Dr. José Serrano
    • Dr. Ana B. Granado-Serrano
    • Dr. Èlia Obis
  • Tests
  • Testimonials
  • FAQS
  • News
  • Contact
  • Account
    • My Courses
    • Login|Logout
My Account
  • About Us
  • Our Courses
    • ONLINE COURSE ON NUTRIGENOMICS FOR PROFESSIONALS OF NUTRITION
    • ONLINE COURSE ON NUTRIGENOMICS FOR HEALTH AND SPORTS
    • ONLINE ADVANCED COURSE ON NUTRIGENETICS AND NUTRIGENOMICS FOR PROFESSIONALS OF NUTRITION
  • Teachers
    • Dr. José Serrano
    • Dr. Ana B. Granado-Serrano
    • Dr. Èlia Obis
  • Tests
  • Testimonials
  • FAQS
  • News
  • Contact
  • Account
    • My Courses
    • Login|Logout

These silent diseases are those that damage the liver without an effective treatment to stop them.

Sep102024

 

Patients suffering from fatty liver and alcoholic liver disease are becoming more frequent. Experts warn that alcohol consumption in Spain is considered the most frequent cause of chronic liver disease.

 

 

The  83rd Congress of the Spanish Society of Digestive Pathology  (SEPD) has devoted a significant amount of space and interest to liver health and pathologies. In this context, specialists have highlighted the impact of  the two most prevalent liver diseases  in our country and the Western world, metabolic – also known as fatty liver – and alcoholic liver, warning that their growth in recent years and the absence of symptoms until the final stages make them two “silent epidemics”.

Faced with this reality and the  lack of effective pharmacological treatments , emphasis has been placed on the need to promote “healthy” measures to combat them: losing weight, exercising, a healthy diet and reducing alcohol consumption, among others.

 

According to  María Casado , president of the  Spanish Digestive System Foundation  (FEAD), ” fatty liver is strongly  associated with overweight and diabetes  and its incidence has been increasing dramatically in recent years. In fact, it currently affects a quarter of the Spanish population and is expected to increase.”

But there is even more compelling data: “One of the most alarming aspects is that it is increasing  in childhood , so that between 30 and 80% of the   overweight pediatric population suffers from fatty liver .” Casado has highlighted that, according to  hepatologists , it is a “silent epidemic” because it is very common, it is increasing and ” it does not give symptoms until very advanced stages .”

What are the keys to this rise? For the expert, the disease is linked to  unhealthy lifestyle habits , which include a sedentary lifestyle and an unhealthy diet (rich in fat and abuse of fast food) and the increase in this lifestyle is causing its greatest impact. But precisely the fact that these factors are “approachable” is a  reason for optimism  for the experts. ” It is a disease that can be prevented in such a simple way through the promotion of healthy lifestyle habits in the population,” Casado commented .

For this reason, this year the FEAD has launched the campaign  A healthy life for a healthy liver , focused on transmitting information and raising awareness among the general population about what  fatty liver is , what its consequences are for health and how to avoid it, banishing a sedentary lifestyle and opting for a healthy or Mediterranean diet.

The expert has insisted that the approach is focused on trying to avoid the factors associated with fatty liver (overweight, obesity and diabetes), since currently, although there are many lines of research and development and clinical trials, “there is no pharmacological treatment authorized in Europe for its treatment.” In her opinion, ” it will take years before we have a drug available  to stop the progression or improve the prognosis of this disease.”

However, positive steps have already been taken in  non-alcoholic steatohepatitis , a type of fatty liver that can progress to cirrhosis and the need for a transplant. In fact, Casado pointed out, “drugs have been developed that reduce inflammation and fibrosis in these patients and one of them has just been approved in the United States” – it is  resmetirom , whose commercial name in the US is  Rezdiffra .

 

ALCOHOL-RELATED LIVER DISEASE

 

The specialist has put forward  another fact that is as compelling as it is alarming : 6% of the Spanish population has an alcohol consumption disorder, with a higher incidence in the male population. Of these, 20% will develop an alcohol-related liver disease, which “silently” will progress to terminal liver disease or cirrhosis of the liver – alcohol consumption is responsible for 70% of cases of cirrhosis in men and more than 50% in women. In addition, this disease will be responsible for the death of one in eight men and one in twelve women who suffer from it.

Regarding the approach to the problem, Casado said: ” At FEAD we want to inform and raise awareness among the population that  pathological or harmful alcohol consumption  can lead to terminal liver disease. And with this we aim to promote the healthy habit of limiting alcohol consumption.”

Once the disease is established, there is only one treatment: abstinence. “ The liver is very grateful  and if, before reaching the final or terminal stages, a patient with this disease stops drinking, within three months the organ can return to normal.” Again, the recommendations focus on “reducing alcohol consumption, a healthy diet, avoiding a sedentary lifestyle and losing weight.”

Regarding what is “tolerable” consumption, Casado has firstly emphasised that ” the safest alcohol consumption is zero “. To visualise where the “danger” begins, he has remarked that specialists “measure this consumption in average units – for example, a glass of wine or a beer. And when it is higher, and sustained over time, than two units of measurement/day for women and four for men, it is already considered harmful in the long term”.

Link: https://www.elmundo.es/ciencia-y-salud/salud/2024/06/18/667002f5e9cf4a1a528b45a6.html

 

Author: Enrique Mezquita Valencia

Date: Updated Tuesday, June 18, 2024 – 16:59

Source: The World

Note: Nutrigenomics Institute is not responsible for the opinions expressed in this article.

Image of Pixabay.

Category: NewsSeptember 10, 2024Leave a comment
Tags: alcoholic steatohepatitisfat livernon-alcoholic steatohepatitis

RELATED POSTS

A committee of experts proposes rethinking the concept of obesity and BMI
January 20, 2025
Scientists discover a “mortality timer” in our cells
January 13, 2025
Gut microbiota: a new path to treat obesity
January 8, 2025
What are dietary exosomes and which foods include them?
December 16, 2024

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Post comment

  • A committee of experts proposes rethinking the concept of obesity and BMI
    January 20, 2025
  • Scientists discover a “mortality timer” in our cells
    January 13, 2025
  • Gut microbiota: a new path to treat obesity
    January 8, 2025
  • What are dietary exosomes and which foods include them?
    December 16, 2024
  • The yo-yo effect: Adipose tissue retains an epigenetic memory of obesity after weight loss
    December 9, 2024